| Literature DB >> 28938400 |
Jie Yu1,2, Sarah L Berga1, Wei Zou3, D Grace Yook1, Joshua C Pan1, Aurora Arroyo Andrade1,4, Lijuan Zhao1,5, Neil Sidell6, Indrani C Bagchi7, Milan K Bagchi8, Robert N Taylor1,2.
Abstract
Inflammation can interfere with endometrial receptivity. We examined how interleukin 1β (IL-1β) affects expression of the uterine gap junction protein connexin 43 (Cx43), which is known to be critical for embryonic implantation. We used an in vitro model of human endometrial stromal cells (ESCs), Western blotting, and a combination of validated, selective kinase inhibitors to evaluate five canonical IL-1β signaling pathways. Cx43 and two other markers of ESC differentiation (prolactin and VEGF) were inhibited predominantly via IL-1β-activated ERK1/2 and p38 MAP kinase cascades. The findings were corroborated using small interfering RNA to silence critical genes in either pathway. By contrast, upregulation of endogenous pro-IL-1α and pro-IL-1β following recombinant IL-1β treatment was mediated via the Jun N-terminal kinase pathway. The clinicopharmacological significance of our findings is that multiple signaling cascades may need to be neutralized to reverse deleterious effects of IL-1β on human endometrial function.Entities:
Mesh:
Substances:
Year: 2017 PMID: 28938400 PMCID: PMC5711380 DOI: 10.1210/en.2017-00495
Source DB: PubMed Journal: Endocrinology ISSN: 0013-7227 Impact factor: 4.736